{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:37:26Z","timestamp":1790347046716,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020439","name":"Jiangsu Pharmaceutical Association","doi-asserted-by":"publisher","award":["Q202219"],"award-info":[{"award-number":["Q202219"]}],"id":[{"id":"10.13039\/100020439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020439","name":"Jiangsu Pharmaceutical Association","doi-asserted-by":"publisher","award":["2023YX018"],"award-info":[{"award-number":["2023YX018"]}],"id":[{"id":"10.13039\/100020439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jchromb.2024.124154","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T23:24:17Z","timestamp":1715297057000},"page":"124154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["LC-MS\/MS and EMIT measure the whole blood concentration of cyclosporine A: The two methods yield concordant results within the dynamic range of the latter, but the former shows broader application scenarios"],"prefix":"10.1016","volume":"1240","author":[{"given":"Yuan-Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jchromb.2024.124154_b0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-101-5-667","article-title":"Cyclosporine: a new immunosuppressive agent for organ transplantation","volume":"101","author":"Cohen","year":"1984","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.jchromb.2024.124154_b0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.biotechadv.2011.03.004","article-title":"Cyclosporin A\u2013a review on fermentative production, downstream processing and pharmacological applications","volume":"29","author":"Survase","year":"2011","journal-title":"Biotechnol. Adv."},{"issue":"20","key":"10.1016\/j.jchromb.2024.124154_b0015","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2174\/0929867327666201006153202","article-title":"Cyclosporine A: Chemistry and Toxicity - A Review","volume":"28","author":"Patocka","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jchromb.2024.124154_b0020","doi-asserted-by":"crossref","unstructured":"M. Oellerich, V.M. Armstrong, E. Sch\u00fctz, L.M. Shaw, Therapeutic drug monitoring of cyclosporine and tacrolimus, Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus, Clin Biochem. 1998;31(5):309-16.Doi: 10.1016\/s0009-9120(98)00049-6.","DOI":"10.1016\/S0009-9120(98)00049-6"},{"issue":"5","key":"10.1016\/j.jchromb.2024.124154_b0025","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaad.2009.05.017","article-title":"Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference","volume":"62","author":"Rosmarin","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9 Suppl","key":"10.1016\/j.jchromb.2024.124154_b0030","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00007890-200205151-00003","article-title":"Patient management by Neoral C(2) monitoring: an international consensus statement","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jchromb.2024.124154_b0035","doi-asserted-by":"crossref","first-page":"3108749","DOI":"10.1155\/2021\/3108749","article-title":"Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data","volume":"2021","author":"Umpi\u00e9rrez","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jchromb.2024.124154_b0040","unstructured":"Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing\/steroid-dependent nephrotic syndrome in children(2016)]. Zhonghua Er Ke Za Zhi. 2017;55(10):729-34.Doi: 10.3760\/cma.j.issn.0578-1310.2017.10.003."},{"key":"10.1016\/j.jchromb.2024.124154_b0045","unstructured":"[Chinese expert consensus on the diagnosis and treatment of aplastic anemia (2017)]. Zhonghua Xue Ye Xue Za Zhi. 2017;38(1):1-5.Doi: 10.3760\/cma.j.issn.0253-2727.2017.01.001."},{"issue":"2","key":"10.1016\/j.jchromb.2024.124154_b0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S2095-1779(11)70024-7","article-title":"The clinical value of enzyme-multiplied immunoassay technique monitoring the plasma concentrations of cyclosporine A after renal transplantation","volume":"1","author":"Luo","year":"2011","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.jchromb.2024.124154_b0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-1759(89)90014-8","article-title":"Antibodies to cyclosporine A (CsA) by a novel route and their use to monitor cyclosporine levels by radioimmunoassay (RIA)","volume":"118","author":"Cacalano","year":"1989","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.jchromb.2024.124154_b0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FTD.0000000000000477","article-title":"Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry for Cyclosporine Analysis in Human Whole Blood and Comparison With an Antibody-Conjugated Magnetic Immunoassay","volume":"40","author":"Mei","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.jchromb.2024.124154_b0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5582\/bst.2017.01121","article-title":"A comparison of liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and enzyme-multiplied immunoassay technique (EMIT) for the determination of the cyclosporin A concentration in whole blood from Chinese patients","volume":"11","author":"Li","year":"2017","journal-title":"Biosci. Trends"},{"issue":"3","key":"10.1016\/j.jchromb.2024.124154_b0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/clinchem\/45.3.371","article-title":"Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?","volume":"45","author":"Steimer","year":"1999","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.jchromb.2024.124154_b0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinbiochem.2006.06.011","article-title":"Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer","volume":"39","author":"Boer","year":"2006","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.jchromb.2024.124154_b0080","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2174\/138920012803341320","article-title":"Strategies for improving the quantitative bioanalytical performance of LC-MS in pharmacokinetic studies","volume":"13","author":"Li","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jchromb.2024.124154_b0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2019.07.026","article-title":"A high-throughput LC-MS\/MS method for the quantification of four immunosu- ppressants drugs in whole blood","volume":"498","author":"Gong","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2024.124154_b0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.talanta.2013.04.027","article-title":"Fast LC-MS\/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery","volume":"115","author":"Koster","year":"2013","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.jchromb.2024.124154_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/FTD.0b013e318192304c","article-title":"Robust, high-throughput LC-MS\/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood","volume":"31","author":"Koster","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"16","key":"10.1016\/j.jchromb.2024.124154_b0100","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.4155\/bio-2019-0143","article-title":"A multidrug LC-MS\/MS method for the determination of five immunosuppressants in oral fluid","volume":"11","author":"Paniagua-Gonz\u00e1lez","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124154_b0105","unstructured":"D.P. Cooper, B.G. Keevil, M.R. Morris, N. Roberts, D.P. Tierney, The development and validation of a rapid LC-MS\/MS method for the monitoring of cyclosporin a in whole blood at peak and trough concentrations."},{"key":"10.1016\/j.jchromb.2024.124154_b0110","doi-asserted-by":"crossref","unstructured":"S. Piccoli, D. Mehta, A. Vitaliti, J. Allinson, S. Amur, S. Eck, et al., White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62). 2019;11(24):2207-44.Doi: 10.4155\/bio-2019-0271, 2019.","DOI":"10.4155\/bio-2019-0271"},{"issue":"11 Pt 1","key":"10.1016\/j.jchromb.2024.124154_b0115","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/clinchem\/39.11.2235","article-title":"Evaluation of EMIT Cyclosporine Assay for use with whole blood","volume":"39","author":"Beresini","year":"1993","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124154_b0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/clinchem\/48.1.69","article-title":"Rapid liquid chromatography-tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range","volume":"48","author":"Keevil","year":"2002","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jchromb.2024.124154_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cccn.2004.12.018","article-title":"Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation","volume":"355","author":"Cattaneo","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jchromb.2024.124154_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-4347(00)00608-3","article-title":"Optimized analytical method for cyclosporin A by high-performance liquid chromatography-electrospray ionization mass spectrometry","volume":"754","author":"Zhou","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"4","key":"10.1016\/j.jchromb.2024.124154_b0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00007691-199408000-00009","article-title":"Cyclosporine in whole blood: drug monitoring difficulties and presentation of a reliable normal-phase liquid chromatographic assay","volume":"16","author":"Poirier","year":"1994","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.jchromb.2024.124154_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1016337817145","article-title":"Effect of column temperature and eluent flow rate on the high performance liquid chromatographic analysis of cyclosporin a and d","volume":"1","author":"Mereish","year":"1984","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.jchromb.2024.124154_b0145","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/clinchem\/44.10.2158","article-title":"Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC","volume":"44","author":"Sch\u00fctz","year":"1998","journal-title":"Clin. Chem."},{"issue":"13","key":"10.1016\/j.jchromb.2024.124154_b0150","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/rcm.7887","article-title":"Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography\/tandem mass spectrometry kit and comparison with immunochemical assays","volume":"31","author":"Polledri","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"5","key":"10.1016\/j.jchromb.2024.124154_b0155","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FTD.0000000000000861","article-title":"Comparison of a Point-of-Care Testing with Enzyme-Multiplied Immunoassay Technique and Liquid Chromatography Combined With Tandem Mass Spectrometry Methods for Therapeutic Drug Monitoring of Mycophenolic Acid: A Preliminary Study","volume":"43","author":"Zhou","year":"2021","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124154_b0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1432-2277.2004.00001.x","article-title":"C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients","volume":"18","author":"Caforio","year":"2005","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124154_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5347(05)67967-0","article-title":"Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?","volume":"163","author":"Mahalati","year":"2000","journal-title":"J. Urol."},{"issue":"10\u201311","key":"10.1016\/j.jchromb.2024.124154_b0170","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.clinbiochem.2008.02.015","article-title":"Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique","volume":"41","author":"Ansermot","year":"2008","journal-title":"Clin. Biochem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:20:15Z","timestamp":1778620815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S1570023224001624"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124154","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC-MS\/MS and EMIT measure the whole blood concentration of cyclosporine A: The two methods yield concordant results within the dynamic range of the latter, but the former shows broader application scenarios","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124154"}}